AEE
51
3
DIS
70
2
UPS
51
6
KEY
24
2
CVS
27
2
ABBV
40
5
KMI
69
8
OI
23
3
LUV
45
3
CCL
68
6
KLAC
45
3
PNC
48
6
EBAY
42
2
SIG
52
5
AMG
33
-11
GIS
47
13
CMS
57
2
KHC
11
2
F
38
4
TAP
57
6
AEE
51
3
DIS
70
2
UPS
51
6
KEY
24
2
CVS
27
2
ABBV
40
5
KMI
69
8
OI
23
3
LUV
45
3
CCL
68
6
KLAC
45
3
PNC
48
6
EBAY
42
2
SIG
52
5
AMG
33
-11
GIS
47
13
CMS
57
2
KHC
11
2
F
38
4
TAP
57
6
Financhill
Back

Avidity Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
13

RNA
Avidity Biosciences

Last Price:
$31.84
Seasonality Move:
38.33%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Sell
13
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $31.82. The Score for RNA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $31.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.35 Sell
Relative Strength Index (14 RSI): 31.67 Sell
Chaikin Money Flow: 247445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.75 - 42.97) Sell
Bollinger Bands (100): (38.89 - 47.21) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.7 Sell
20-day SMA: 37.3 Sell
50-day SMA: 42.36 Sell
200-day SMA: 37.02 Sell
8-day EMA: 32.94 Sell
20-day EMA: 36.33 Sell
50-day EMA: 40.15 Sell
200-day EMA: 36.08 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.26 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):